2013-10-18T16:06:17-07:00 2012-12-31 Kimerling & Wisdom LLC 150 Broadway Suite 1105 New York NY 10038 990 2012-01-01 522275294 THE SARCOMA FOUNDATION OF AMERICA INC SARC 3012538687 9899 MAIN STREET SUITE 204 DAMASCUS MD 20872 ANTHONY FERLENDA 2013-10-18 true Ross Wisdom CPA P00163343 2129860892 2012 2016-02-24 21:20:13Z 3096445 false false X www.curesarcoma.org X 2001 MD PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. 13 13 8 50 0 1365483 2421291 0 40549 36253 25129 44 1431161 2457588 598321 663078 0 427842 451802 147348 86400 307561 423907 499077 1597418 1700357 -166257 757231 2014825 2836257 251877 252311 1762948 2583946 PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. false false 1157413 663078 2421291 PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. 1157413 true true false true false false false false false false true false false false true false true false false false false false false true true false false true false true false false false false false false false false false false false true false false false false false false false false false true 12 0 true 8 true false false false false false true true true true false 0 false false false false false false false false false false X 13 13 true false false false false false false true true false false true true true true true true true true false WV WI WA VA UT TN SC RI PA OR NY NJ NC MS MN MI MD MA KY IL GA FL CT CA X X ORGANIZATION 3012538687 9899 MAIN STREET SUITE 204 DAMASCUS MD 20872 RITA SAVERINO ROMEO 1.00 0.00 X 0 0 0 CHRIS CONNERY 1.00 0.00 X 0 0 0 CANDACE SUE 1.00 0.00 X 0 0 0 MICHAEL MANDELL 1.00 0.00 X 0 0 0 PATRICK MORTIMER 1.00 0.00 X 0 0 0 ANTHONY FEDOROV 1.00 0.00 X 0 0 0 THOMAS TOBIN 1.00 0.00 X X 0 0 0 JOHN SJ BROOKS MD 1.00 0.00 X 0 0 0 ALEXANDRA GILLESPIE 1.00 0.00 X 0 0 0 STACEY BREIDINGER 1.00 0.00 X X 0 0 0 GARY TOMEI ESQ 1.00 0.00 X X 0 0 0 PATRICIA THORNTON 8.00 0.00 X 0 0 0 MARK THORNTON MD PhD 4.00 0.00 X X 0 0 0 ANTHONY F FERLENDA 40.00 0.00 X 40308 0 0 MATTHEW ALSANTE 40.00 0.00 X 66459 0 0 106767 0 true false true REGISTRY PARTNERS 2966 SOUTH CHURCH ST PMB 293 BURLINGTON NC 27215 PATIENT REGISTRY 281987 POWERED BY PROFESSIONALS INC 1375 BROADWAY THIRD FLOOR NEW YORK NY 10018 ANNUAL GALA 86400 1 831247 1590044 10098 2421291 0 56321 56321 0 0 0 299368 317611 1825 -18243 -1825 -20068 -20068 319421 831247 319421 0 0 0 REIMB EXPS & MISC. 900099 44 44 44 2457588 -20024 56321 663078 663078 0 0 0 106767 57802 30337 18628 0 261081 66684 73920 120477 6755 2224 2046 2485 47389 16112 13269 18008 29810 10135 8347 11328 0 1250 1250 10480 10480 0 86400 86400 13992 13992 0 0 5915 752 5163 9860 2239 7358 263 0 31709 31709 25176 16648 1451 7077 0 7211 4583 2628 0 0 6274 6274 5805 5805 Postage and Shipping 10742 4306 1752 4684 Printing and Publications 16459 7811 672 7976 ADVERTISING & MARKETING 24508 8193 16315 PATIENT REGISTRY 282029 282029 47667 14817 18930 13920 1700357 1157413 235383 307561 78211 75910 465794 242311 21717 1578 1119194 0 0 0 0 27861 42185 38966 20897 23681 18069 594571 1332555 799074 0 0 0 3916 4455 2014825 2836257 43533 60702 190821 162078 11130 17523 18401 251877 252311 X 1285237 1053612 477711 1530334 1762948 2583946 2014825 2836257 X 757231 63767 X false true X true false X 1079610 996345 1365250 1365483 2420041 7226729 0 0 0 0 1079610 996345 1365250 1365483 2420041 7226729 0 0 7226729 44637 35190 36965 40549 56321 213662 0 44637 35190 36965 40549 56321 213662 0 15187 38 628 25129 44 41026 1139434 1031573 1402843 1431161 2476406 7481417 0.96600 0.95920 0.02860 0.03400 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false 2419 2419 1151994 1154413 190441 47610 false 182043 190441 372484 558726 65605 2419 68024 45511 47610 93121 139682 101 101 29463 13113 16350 9503 7784 1719 18069 Salary payable 16174 PAYROLL TAX PAYABLE 1517 Benefits payable 710 18401 2541423 83835 83835 2457588 2457588 1720425 20068 20068 1700357 1700357 Part XII, Line 2d Part XII, Line 2d: Other expenses and losses per audited F/S Realized gains & losses $20068 Part XI, Line 2d Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990 Realized gains & losses $20068 Unrealized gains & losses $63767 X X X false POWERED BY PROF 1375 BROADWAY NEW YORK NY 10018 ANNUAL GALA false 785511 86400 699111 785511 86400 699111 WV UT TN RI MS WI WA VA SC PA OR NY NJ NC MN MI MD MA IL GA FL CT CA GALA 844675 584383 260292 59564 24133 76875 99720 PA 5K 121580 104155 17425 17425 5 178053 138407 39646 5045 4263 30338 1144308 826945 317363 59564 29178 81138 147483 317363 true WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE SAINT LOUIS MO 63112 430653611 501C3 50000 0 CANCER RESEARCH UPCIUMPC CANCER CENTERS UPMC CANCER PAVILLION STE 1B PITTSBURGH PA 15232 250965591 501C3 52078 0 CANCER RESEARCH UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE 406 SALT LAKE CITY UT 84112 876000525 501C3 50000 0 CANCER RESEARCH STANFORD UNIVERSITY 301 RAVENSWOOD DRIVE 2ND FL MENLO PARK CA 94025 944156365 501C3 50000 0 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANC 633 THIRD AVENUE 28TH FLOOR NEW YORK NY 10017 131924236 501C3 100000 0 CANCER RESEARCH JOHNS HOPKINS UNIVERSITY 12529 COLLECTIONS CENTER DR CHICAGO IL 60693 520595110 501C3 50000 0 CANCER RESEARCH CONQUER CANCER FOUNDATION 2318 MILL ROAD SUITE 800 ALEXANDRIA VA 22314 311667995 501C3 110000 0 CANCER RESEARCH CHILDRENS HOSPITAL LA 4650 SUNSET BLVD MAIL STOP 97 LOS ANGELES CA 90027 951690977 501C3 50000 0 CANCER RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD 65-WIL 1150 LOS ANGELES CA 90048 951644600 501C3 100000 0 CANCER RESEARCH BAYLOR COLLEGE OF MEDICINE PO BOX 201361 HOUSTON TX 77216 741613878 501C3 50000 0 CANCER RESEARCH 12 2 Grantmaker's Description of How Grants are Used Applicants for SFA grants must submit an application outlining their proposed research project along with a detailed budget that demonstrates how the award money is to be used. Applicants are made aware that a requirement of the acceptance of grant money is that a final report will be submitted to the SFA at the end of the one-year grant period. The final report is due to the SFA by July 31 of the year after the award is made. Final reports are to contain information on how the research progressed and it must be signed by both the primary investigator as well as their department chair. false false false false false false false false false false MATTHEW ALSANTE 66459 66459 ANTHONY F FERLENDA 40308 40308 X 12665 MARKET VALUE X 1 9606 MARKET VALUE 7 1345 MARKET VALUE 5 2540 MARKET VALUE MISCELLANEOUS 3 6100 MARKET VALUE TRIPS 7 5720 MARKET VALUE SPORTING EVENTS 6 2250 MARKET VALUE MEALS/RESTAURAN 13 4375 MARKET VALUE PERSONAL CARE 4 465 MARKET VALUE JEWERLY 5 1620 MARKET VALUE ENTERTAINMENT 4 2874 MARKET VALUE ELECTRONICS 2 900 MARKET VALUE CONCERT TICKETS 3 710 MARKET VALUE X VARIOUS - SEE SCHEDULE M 1 29556 MARKET VALUE X TRIPS 1 8000 MARKET VALUE X GIFTS CERTIFICATE - PORTRAITS 1 5000 MARKET VALUE X TRIPS 1 10000 MARKET VALUE false false false Form 990, Part XI, Line 9 Other Changes In Net Assets Or Fund Balances - Other Increases UNREALIZED GAINS & LOSSES = $63767 Form 990, Part VI, Line 19 Form 990, Part VI, Line 19: Other Organization Documents Publicly Available Governing documents, conflict of interest policy are available upon request, financial statements are available on the website as well as on request. Form 990, Part VI, Line 15b Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees The Board of Directors has an appointed compensation committee that reviews and approves the salary of the executive director on an annual basis using current economic comparative data. Form 990, Part VI, Line 15a Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management The Board of Directors has an appointed compensation committee that reviews and approves the salary of the CEO on an annual basis using current economic comparative data. Form 990, Part VI, Line 12c Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts At least once a year, each person acting on behalf of the Sarcoma Foundation of America, Inc., shall execute and submit a statement to the president and CEO disclosing all material facts concerning any actual or potential conflict of interest or confirming that there are no such conflicts to be disclosed. Form 990, Part VI, Line 11b Form 990, Part VI, Line 11b: Form 990 Review Process The Bookkeeper assistant treasurer and CEO (officer) review the 990 based on the financial records, policies and programs of the organization. Form 990, Part VI, Line 2 Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et MARK THORNTON (PRESIDENT) AND PATRICIA THORNTON (ASSISTANT TREASURER) ARE HUSBAND AND WIFE. Client Note 1 - Will work to effect, though congressional action. changes to the FDA regulatory process which would consistently and predictably utilize progression free survival as the primary endpoint for and basis full approval of, new drugs for rare cancers.